Shattuck Labs Ownership | Who Owns Shattuck Labs?
Shattuck Labs Ownership Summary
Shattuck Labs is owned by 9.57% institutional investors, 11.04% insiders, and 79.39% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.36% of STTK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.65% of its assets in Shattuck Labs shares.
STTK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Shattuck Labs | 9.57% | 11.04% | 79.39% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 6.31M | 12.36% | $15.07M |
| Adage capital partners gp | 6.31M | 12.36% | $15.07M |
| Redmile group | 5.54M | 10.86% | $13.24M |
| Prosight management, lp | 5.45M | 10.69% | $13.03M |
| Blackrock | 2.47M | 4.89% | $9.55M |
| Vanguard group | 2.13M | 4.17% | $5.09M |
| 683 capital management | 1.53M | 3.00% | $3.66M |
| Clark estates inc/ny | 1.48M | 2.89% | $3.53M |
| Pinnacle associates | 1.39M | 2.72% | $3.32M |
| Marshall wace, llp | 656.65K | 1.29% | $1.57M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Takeda pharmaceutical | 515.62K | 7.53% | $1.23M |
| Prosight management, lp | 5.45M | 3.04% | $13.03M |
| Redmile group | 5.54M | 1.29% | $13.24M |
| Clark estates inc/ny | 1.48M | 0.81% | $3.53M |
| Orbimed advisors | 6.31M | 0.36% | $15.07M |
| 683 capital management | 1.53M | 0.19% | $3.66M |
| Lbj family wealth advisors | 82.18K | 0.11% | $196.00K |
| Piper sandler | 39.47K | 0.07% | $94.33K |
| Pinnacle associates | 1.39M | 0.04% | $3.32M |
| Adage capital partners gp | 6.31M | 0.02% | $15.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | 6.31M | 0.36% | 6.31M |
| Blackrock | 2.47M | 0.00% | 1.94M |
| Adage capital partners gp | 6.31M | 0.02% | 1.63M |
| Marshall wace, llp | 656.65K | 0.00% | 656.65K |
| 683 capital management | 1.53M | 0.19% | 437.22K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | - | - | -1.57M |
| Prosight management, lp | 5.45M | 3.04% | -1.19M |
| Laurion capital management lp | - | - | -661.04K |
| Blackrock funding, inc. /de | 411.29K | - | -470.10K |
| Goldman sachs group | 16.80K | - | -308.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Orbimed advisors | 6.31M | 0.36% | 6.31M | $15.07M |
| Marshall wace, llp | 656.65K | 0.00% | 656.65K | $1.57M |
| Abrdn | 94.50K | 0.00% | 94.50K | $225.87K |
| Xtx topco | 26.23K | 0.00% | 26.23K | $62.68K |
| Squarepoint ops | 19.26K | - | 19.26K | $46.03K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -6.00 |
| True wealth design | -46.00 |
| Eversource wealth advisors | -112.00 |
| Federated hermes | -152.00 |
| Clearstead advisors | -155.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 16 | -71.93% | 4,882,311 | -82.75% | 9 | 0.31% | 6 | -78.57% | 6 | -68.42% |
| Jun 30, 2025 | 61 | -18.67% | 28,684,223 | -8.03% | 56 | 1.50% | 30 | 20.00% | 21 | -12.50% |
| Mar 31, 2025 | 5 | -93.24% | 12,594,508 | -60.18% | 24 | 0.64% | 2 | -94.87% | 1 | -94.44% |
| Dec 31, 2024 | 21 | -72.73% | 7,490,701 | -79.01% | 14 | 0.30% | 11 | -74.42% | 3 | -83.33% |
| Sep 30, 2024 | 77 | 2.67% | 35,694,485 | 6.30% | 70 | 1.59% | 43 | -17.31% | 18 | 28.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.22M | 4.65% | 12.22K |
| Fidelity Growth Compy Commingled Pl O | 2.21M | 4.63% | - |
| Fidelity Advisor Biotechnology I | 1.32M | 2.76% | - |
| Vanguard US Total Market Shares ETF | 1.31M | 2.74% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.29M | 2.69% | -28.12K |
| Fidelity Growth Company Fund | 1.28M | 2.68% | -2.72K |
| Franklin Biotechnology Discv A(acc)USD | 1.06M | 2.23% | - |
| Fidelity Series Small Cap Opps | 622.74K | 1.30% | - |
| Fidelity Growth Company K6 | 550.52K | 1.15% | -9.50K |
| Franklin Biotechnology Discovery A | 505.80K | 1.06% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $1.01K |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $4.56M |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $3.33M |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $202.23 |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $16.67M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | 1 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | 3 |
STTK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools